Health
Hundreds of Studies Show DMSO Transforms The Treatment of Cancer
The Forgotten Side of Medicine by A Midwestern Doctor
It might not be something your doctor wants to talk about, but it certainly is something we should all know more about. The video from an old 60 Minutes episode is a must see.
Dimethyl Sulfoxide (DMSO)
Exactly six months ago, I used this newsletter to bring the public’s attention to DMSO, a simple naturally occurring compound that has a number of immense therapeutic benefits and virtually no toxicity (detailed here). In turn, when it was discovered in the 1960s, it quickly became America’s most desired drug (as it cured many incurable ailments). A lot of the scientific community promptly got behind it and before long, thousands of papers had been published on every conceivable medical application for it. Consider for example this 1980 program 60 Minutes aired on DMSO:
As such, throughout this series, I’ve presented the wealth of evidence that DMSO effectively treats:
Strokes, paralysis, a wide range of neurological disorders (e.g., Down Syndrome and dementia), and many circulatory disorders (e.g., Raynaud’s, varicose veins, hemorrhoids), which I discussed here.
A wide range of tissue injuries, such as sprains, concussions, burns, surgical incisions, and spinal cord injuries (discussed here).
Chronic pain (e.g., from a bad disc, bursitis, arthritis, or complex regional pain syndrome), which I discussed here.
A wide range of autoimmune, protein, and contractile disorders such as scleroderma, amyloidosis, and interstitial cystitis (discussed here).
A variety of head conditions, such as tinnitus, vision loss, dental problems, and sinusitis (discussed here).
A wide range of internal organ diseases such as pancreatitis, infertility, liver cirrhosis, and endometriosis (discussed here).
A wide range of skin conditions such as burns, varicose veins, acne, hair loss, ulcers, skin cancer, and many autoimmune dermatologic diseases (discussed here).
Many challenging infectious conditions, including chronic bacterial infections, herpes, and shingles (discussed here).
In turn, when I published this series (because of both how effective and easily accessible DMSO is) it caught on like wildfire, this publication went from being the ninth to top ranked newsletter in the genre, there was a nationwide DMSO shortage, and I’ve received almost two thousand testimonials from people who benefitted from DMSO (and often had remarkable results—particularly for chronic pain).
That response was quite surprising and in my eyes, a testament not only to how well DMSO works, but more importantly, how effectively DMSO’s story was erased from history (e.g., many long-time enthusiasts of natural health shared that they were blown away they’d never heard of it). This sadly illustrates how effectively the medical industry can bury anything threatening its bottom line (e.g., the FDA—for rather petty reasons—used everything at their disposal to make sure DMSO was forgotten).
In turn, within the DMSO story, I believe one of the least appreciated (or even known) facets of it are the remarkable contributions DMSO makes to the treatment of cancer—which is even more remarkable given that far more research has been done with DMSO and cancer than all the other topics I just listed. Consequently, for months I’ve wanted to publish an article on this (particularly since one incredible natural cancer therapy utilizes DMSO), but simultaneously, it just wasn’t feasible to as there was so much literature to go through.
That’s been weighing on me considerably (e.g. many readers have asked me to prioritize this article over everything else), so over the last three months (and particularly the last three weeks), I shifted my responsibilities to focus on the topic thoroughly. While it took a bit of a toll on me, the article is now done. As such, I greatly hope some of what’s in here can benefit you and I likewise thank each of you who has supported this newsletter and made it possible for me to spend so much time delving into these critical forgotten sides of medicine.
The Forgotten Side of Medicine is a reader-supported publication. To receive new posts and support my work, please consider becoming a free or paid subscriber. To see how others have benefitted from this newsletter, click here!
Story at a Glance:
- Dimethyl sulfoxide (DMSO) effectively treats a broad spectrum of conditions, including strokes, pain, tissue injuries, autoimmune inflammation, and cancer.
- DMSO inhibits cancer growth and consistently reverts cancer cells to their normal state.
- DMSO enhances cancer visibility to immune cells, enabling the body to eliminate tumors previously undetected by the immune system.
- DMSO effectively mitigates major challenges in conventional cancer care, such as radiation damage, chemotherapy toxicity, and pain from “incurable” metastatic cancer.
- DMSO markedly boosts the efficacy of many chemotherapy drugs, allowing safer, lower doses to achieve the same results.
- When paired with certain natural therapies, DMSO often produces highly effective cancer treatments, revolutionizing cancer care.
Cancer is one of the most challenging conditions to deal with in medicine, as two seemingly identical cancers can have very different causes. As a result, any standardized (holistic or conventional) protocol will inevitably fail some of the patients it is meant to treat.
Furthermore, since there is so much fear surrounding cancer (e.g., from what the primal fear brings up inside you, from how your social circle reacts to it and from how the medical system uses all of that to push cancer therapies) it is often very difficult to have a clear head about the ordeal or find the right source of advice.
Likewise, since so much money is involved (e.g. 65% of oncologist’s revenues comes from chemotherapy drugs and cancer drugs are by far the most profitable drug market), there is significant pushback (e.g. from medical boards or unhappy relatives) against anyone who attempts alternative cancer therapies making it very difficult to practice unconventional cancer care—particularly since no alternative treatment works all the time.
Note: in a recent article, I highlighted how urologists initially would not touch Lupron (which is now also used as a the puberty blocker) because of how unsafe and ineffective it was, but once they started being paid a lot of money to prescribe it for prostate cancer, it rapidly became their number one drug.
In contrast, while the conventional cancer therapies often have serious issues that make them far worse than any benefit they offer, some conventional cancer therapies are frequently the only available option which can save someone’s life (which has led to me at different times having fights with close friends or relatives either not to do chemotherapy or to get them to start it in cases where I felt it was absolutely necessary).
Given all of this, I presently believe that no “ideal” cancer treatment exists, but if it can be done (e.g., it’s effective for the cancer and feasible to implement), the most ideal to least ideal treatments are as follows:
•Identifying the root cause of a cancer, removing it, and having it quickly and permanently go away on its own (which is sometimes possible).
•Have enough time to rebalance the body so that its terrain no longer supports the cancer and the cancer can fade away on its own (which is often doable but a fairly involved process many have difficulty carrying out).
•Significantly enhance the function of the immune system so that it will eliminate the cancer.
•Find a treatment that is toxic to the cancer but relatively benign to the rest of the body.
•Find a treatment with an acceptable toxicity level and find ways to mitigate its effects.
•Accept a moderately toxic treatment with significant side effects.
•Focus on living with the cancer rather than curing it and then finding ways to mitigate the symptoms you experience both from it and any existing treatment protocols.
•Use a costly conventional therapy that is unlikely to work and live with all the side effects until your life ends (which in more extreme treatment regimens can be quite severe).
If we take a step back, what’s truly remarkable about DMSO, depending on how it is used, is that it can effectively provide most of the benefits listed above with the least amount of collateral damage (e.g., side-effects, toxicity, etc.).
Alberta
A Christmas wish list for health-care reform
From the Fraser Institute
By Nadeem Esmail and Mackenzie Moir
It’s an exciting time in Canadian health-care policy. But even the slew of new reforms in Alberta only go part of the way to using all the policy tools employed by high performing universal health-care systems.
For 2026, for the sake of Canadian patients, let’s hope Alberta stays the path on changes to how hospitals are paid and allowing some private purchases of health care, and that other provinces start to catch up.
While Alberta’s new reforms were welcome news this year, it’s clear Canada’s health-care system continued to struggle. Canadians were reminded by our annual comparison of health care systems that they pay for one of the developed world’s most expensive universal health-care systems, yet have some of the fewest physicians and hospital beds, while waiting in some of the longest queues.
And speaking of queues, wait times across Canada for non-emergency care reached the second-highest level ever measured at 28.6 weeks from general practitioner referral to actual treatment. That’s more than triple the wait of the early 1990s despite decades of government promises and spending commitments. Other work found that at least 23,746 patients died while waiting for care, and nearly 1.3 million Canadians left our overcrowded emergency rooms without being treated.
At least one province has shown a genuine willingness to do something about these problems.
The Smith government in Alberta announced early in the year that it would move towards paying hospitals per-patient treated as opposed to a fixed annual budget, a policy approach that Quebec has been working on for years. Albertans will also soon be able purchase, at least in a limited way, some diagnostic and surgical services for themselves, which is again already possible in Quebec. Alberta has also gone a step further by allowing physicians to work in both public and private settings.
While controversial in Canada, these approaches simply mirror what is being done in all of the developed world’s top-performing universal health-care systems. Australia, the Netherlands, Germany and Switzerland all pay their hospitals per patient treated, and allow patients the opportunity to purchase care privately if they wish. They all also have better and faster universally accessible health care than Canada’s provinces provide, while spending a little more (Switzerland) or less (Australia, Germany, the Netherlands) than we do.
While these reforms are clearly a step in the right direction, there’s more to be done.
Even if we include Alberta’s reforms, these countries still do some very important things differently.
Critically, all of these countries expect patients to pay a small amount for their universally accessible services. The reasoning is straightforward: we all spend our own money more carefully than we spend someone else’s, and patients will make more informed decisions about when and where it’s best to access the health-care system when they have to pay a little out of pocket.
The evidence around this policy is clear—with appropriate safeguards to protect the very ill and exemptions for lower-income and other vulnerable populations, the demand for outpatient healthcare services falls, reducing delays and freeing up resources for others.
Charging patients even small amounts for care would of course violate the Canada Health Act, but it would also emulate the approach of 100 per cent of the developed world’s top-performing health-care systems. In this case, violating outdated federal policy means better universal health care for Canadians.
These top-performing countries also see the private sector and innovative entrepreneurs as partners in delivering universal health care. A relationship that is far different from the limited individual contracts some provinces have with private clinics and surgical centres to provide care in Canada. In these other countries, even full-service hospitals are operated by private providers. Importantly, partnering with innovative private providers, even hospitals, to deliver universal health care does not violate the Canada Health Act.
So, while Alberta has made strides this past year moving towards the well-established higher performance policy approach followed elsewhere, the Smith government remains at least a couple steps short of truly adopting a more Australian or European approach for health care. And other provinces have yet to even get to where Alberta will soon be.
Let’s hope in 2026 that Alberta keeps moving towards a truly world class universal health-care experience for patients, and that the other provinces catch up.
Health
FDA warns ‘breast binder’ manufacturers to stop marketing to gender-confused girls
From LifeSiteNews
Dr. Marty Makary took aim at the transgender-medical-industrial complex that has exploded in recent years during a recent press conference.
Food and Drug Administration (FDA) commissioner Dr. Marty Makary has sternly warned companies manufacturing “breast binders” to cease marketing and supplying their product to gender-confused girls seeking to make their bodies appear masculine.
“Today the FDA is taking action,” said Makary in a press conference. “We are sending warning letters to 12 manufacturers and retailers for illegal marketing of breast binders for children, for the purposes of treating gender dysphoria.”
“Breast binders are a class one medical device with legitimate medical users, such as being used by women after breast cancer surgery,” but “these binders are not benign,” he cautioned. “Long-term usage has been associated with pain, compromised lung function, and even difficulty breast feeding later in life.”
“The warning letters will formally notify the companies of their significant regulatory violations and require prompt corrective action,” said the FDA head.
.@DrMakaryFDA: “Today the FDA is taking action. We are sending warning letters to 12 manufacturers and retailers for illegal marketing of breast binders for children, for the purposes of treating gender dysphoria.” pic.twitter.com/6JNAy36223
— HHS Rapid Response (@HHSResponse) December 18, 2025
The warning letter addressed to California manufacturer, GenderBender, notes that the company’s website states that “[c]hest binding is the practice of compressing breast mass into a more masculine shape, often done in the LGBTQ community for gender euphoria.”
“Your firm should take prompt action to address any violations identified in this letter. Failure to adequately address this matter may result in regulatory action being initiated by the FDA without further notice. These actions include, but are not limited to, seizure and injunction,” advised the FDA.
During his presentation, Makary took aim at the transgender-medical-industrial complex that has exploded in recent years.
“One of the most barbaric features of a society is the genital mutilation of its children,” observed Makary.
“Pushing transgender ideology in children is predatory, it’s wrong, and it needs to stop,” he declared.
“This ideology is a belief system that some teachers, some pediatricians, and others are selling to children without their parents knowing sometimes, or with a deliberate attempt to remove parents from the decision making,” Makary explained.
To witness society “putting kids on a path of chest binders, drugs, castration, mastectomies, and other procedures is a path that now many kids regret,” he lamented, as he pointed to Chloe Cole, who has reverted to her God-given femininity after undergoing so-called “gender-affirming” surgery as a teen.
Cole is a leading voice for young people who have “detransitioned” after having medically, surgically, and socially attempted to “transition” to a member of the opposite sex.
.@DrMakaryFDA: “Pushing transgender ideology in children is predatory, it's wrong, and it needs to stop.” pic.twitter.com/TXxWNEtNZk
— HHS Rapid Response (@HHSResponse) December 18, 2025
-
Alberta2 days agoOttawa-Alberta agreement may produce oligopoly in the oilsands
-
Energy2 days agoThe Top News Stories That Shaped Canadian Energy in 2025 and Will Continue to Shape Canadian Energy in 2026
-
Energy2 days agoWestern Canada’s supply chain for Santa Claus
-
International2 days ago$2.6 million raised for man who wrestled shotgun from Bondi Beach terrorist
-
Frontier Centre for Public Policy17 hours agoTent Cities Were Rare Five Years Ago. Now They’re Everywhere
-
armed forces18 hours agoRemembering Afghanistan and the sacrifices of our military families
-
Fraser Institute18 hours agoHow to talk about housing at the holiday dinner table
-
Fraser Institute3 hours agoCarney government sowing seeds for corruption in Ottawa



